regulator pain drug
food drug regulators decide recommend painkillers linked heart stroke
food drug fda advisory panel verdict hearing painkillers inhibitors brand names celebrex vioxx vioxx withdrawn shops merck selling fda approval fda decide benefits patients justify risks
putting vioxx shelves boost profits merck easier battles injured drug
merck voluntarily stopped vioxx september caused earnings slide merck shares tumbled millions dollars cover litigation alarm bells rung note approve heart stroke doubled patients drug inhibitors developed drug merck pfizer users fewer stomach painkillers
pfizer selling celebrex bextra investigations harmful heart merck announcement reintroduction vioxx caught surprise merck peter kim withdrew vioxx knowing alternative therapies changed light cardiovascular observed approve vioxx unique class drugs marketed kim explained
graham fda drug safety advisory panel inhibitors calculations senate dr graham vioxx linked deaths facing stem criticism handling vioxx fda body oversee safety drugs regulators ruled patients heart disease stroke inhibitors medicines agency doctors cautious drugs patients factors heart disease
